Sophie A Palitz1, Nicole E Caporino2, Joseph F McGuire3, John Piacentini4, Anne Marie Albano5, Boris Birmaher6, John T Walkup7, Scott N Compton8, Golda S Ginsburg9, Philip C Kendall10. 1. Temple University, Philadelphia, PA. Electronic address: sophie.palitz@temple.edu. 2. American University, Washington, DC. 3. Division of Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, MD. 4. University of California, Los Angeles School of Medicine. 5. New York State Psychiatric Institute and Columbia University Medical Center, NY. 6. University of Pittsburgh School of Medicine, Pittsburgh, PA. 7. Weill Cornell Medicine and New York-Presbyterian Hospital, NY. 8. Duke University Medical Center, Durham, NC. 9. University of Connecticut Health Center, Storrs. 10. Temple University, Philadelphia, PA.
Abstract
OBJECTIVE: To determine the percent reduction cutoffs on the Multidimensional Anxiety Scale for Children (MASC) that optimally predict treatment response and remission in youth with anxiety disorders. METHOD: Youths and their parents completed the MASC-C/P before and after treatment, and the Anxiety Disorders Interview Schedule for DSM-IV-Child and Parent Versions (ADIS-IV-C/P) and the Clinical Global Impression-Improvement Scale (CGI-I) were administered by independent evaluators. Treatment response and remission were defined by post-treatment ratings on the CGI-I and the ADIS-IV-C/P, respectively. Quality receiver operating characteristic methods determined the optimal cutoff on the MASC-P for predicting overall remission (loss of all study entry diagnoses) and optimal percent reductions on the MASC-P for predicting treatment response and remission of separation anxiety, social anxiety, and generalized anxiety. RESULTS: A post-treatment raw score of 42 optimally predicted remission. A reduction of 35% on the total MASC-P predicted treatment response. A reduction of 30% on the Separation Anxiety/Panic subscale of the MASC-P predicted separation anxiety remission. A reduction of 35% on the Social Anxiety subscale of the MASC-P predicted social anxiety remission. The MASC did not evidence a cutoff for remission of generalized anxiety disorder. CONCLUSION: MASC cutoffs can facilitate comparison across studies and guide practice, aiding clinicians in assessing progress and informing treatment plans.
OBJECTIVE: To determine the percent reduction cutoffs on the Multidimensional Anxiety Scale for Children (MASC) that optimally predict treatment response and remission in youth with anxiety disorders. METHOD: Youths and their parents completed the MASC-C/P before and after treatment, and the Anxiety Disorders Interview Schedule for DSM-IV-Child and Parent Versions (ADIS-IV-C/P) and the Clinical Global Impression-Improvement Scale (CGI-I) were administered by independent evaluators. Treatment response and remission were defined by post-treatment ratings on the CGI-I and the ADIS-IV-C/P, respectively. Quality receiver operating characteristic methods determined the optimal cutoff on the MASC-P for predicting overall remission (loss of all study entry diagnoses) and optimal percent reductions on the MASC-P for predicting treatment response and remission of separation anxiety, social anxiety, and generalized anxiety. RESULTS: A post-treatment raw score of 42 optimally predicted remission. A reduction of 35% on the total MASC-P predicted treatment response. A reduction of 30% on the Separation Anxiety/Panic subscale of the MASC-P predicted separation anxiety remission. A reduction of 35% on the Social Anxiety subscale of the MASC-P predicted social anxiety remission. The MASC did not evidence a cutoff for remission of generalized anxiety disorder. CONCLUSION: MASC cutoffs can facilitate comparison across studies and guide practice, aiding clinicians in assessing progress and informing treatment plans.
Authors: Corinne Hannan; Michael J Lambert; Cory Harmon; Stevan Lars Nielsen; David W Smart; Kenichi Shimokawa; Scott W Sutton Journal: J Clin Psychol Date: 2005-02
Authors: Philip C Kendall; Scott N Compton; John T Walkup; Boris Birmaher; Anne Marie Albano; Joel Sherrill; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; Lindsey Bergman; Dara Sakolsky; Cindy Suveg; Satish Iyengar; John March; John Piacentini Journal: J Anxiety Disord Date: 2010-02-06
Authors: L C Dierker; A M Albano; G N Clarke; R G Heimberg; P C Kendall; K R Merikangas; P M Lewinsohn; D R Offord; R Kessler; D J Kupfer Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-08 Impact factor: 8.829
Authors: Jennifer L Hudson; Ronald M Rapee; Charise Deveney; Carolyn A Schniering; Heidi J Lyneham; Nataly Bovopoulos Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-05 Impact factor: 8.829
Authors: Nicole E Caporino; Douglas M Brodman; Philip C Kendall; Anne Marie Albano; Joel Sherrill; John Piacentini; Dara Sakolsky; Boris Birmaher; Scott N Compton; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; John March; John T Walkup Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-11-30 Impact factor: 8.829
Authors: Joseph F McGuire; Nicole E Caporino; Sophie A Palitz; Philip C Kendall; Anne Marie Albano; Golda S Ginsburg; Boris Birmaher; John T Walkup; John Piacentini Journal: Depress Anxiety Date: 2019-06-24 Impact factor: 6.505